References
- PautlerMBrennerSNanomedicine: promises and challenges for the future of public healthInt J Nanomedicine2010580380921042425
- Ferrer-MirallesNVazquezEVillaverdeAMembrane-active peptides for non-viral gene therapy: making the safest easierTrends Biotechnol20082626727518358551
- MillettiFCell-penetrating peptides: classes, origin, and current landscapeDrug Discov Today3232012 [Epub ahead of print.]
- PeledAWaldOBurgerJDevelopment of novel CXCR4-based therapeuticsExpert Opin Investig Drugs201221341353
- WilenCBTiltonJCDomsRWMolecular mechanisms of HIV entryAdv Exp Med Biol201272622324222297516
- KlonischTWiechecEHombach-KlonischSCancer stem cell markers in common cancers – therapeutic implicationsTrends Mol Med20081445046018775674
- SunXChengGHaoMCXCL12/CXCR4/CXCR7 chemokine axis and cancer progressionCancer Metastasis Rev20102970972220839032
- KimJMoriTChenSLChemokine receptor CXCR4 expression in patients with melanoma and colorectal cancer liver metastases and the association with disease outcomeAnn Surg200624411312016794396
- LiangZYoonYVotawJGoodmanMMWilliamsLShimHSilencing of CXCR4 blocks breast cancer metastasisCancer Res20056596797115705897
- LiangXCXCR4, inhibitors and mechanisms of actionChem Biol Drug Des2008729711018624812
- MurakamiTZhangTYKoyanagiYInhibitory mechanism of the CXCR4 antagonist t22 against human immunodeficiency virus type 1 infectionJ Virol1999737489749610438838
- BradfordMMA rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnal Biochem197672248254942051
- VazquezERoldanMDíez-GilCProtein nanodisk assembling and intracellular trafficking powered by an arginine-rich (R9) peptideNanomedicine (Lond)2010525926820148637
- VazquezECubarsiRUnzuetaUInternalization and kinetics of nuclear migration of protein-only, arginine-rich nanoparticlesBiomaterials2010319333933920869766
- Seras-FranzosoJDíez-GilCVazquezEBioadhesiveness and efficient mechanotransduction stimuli synergistically provided by bacterial inclusion bodies as scaffolds for tissue engineeringNanomedicine (Lond)20127799322142409
- BarberaVMMartinMMarinosoLThe 18q21 region in colorectal and pancreatic cancer: independent loss of DCC and DPC4 expressionBiochim Biophys Acta2000150228329611040453
- BaigMSManickamNHomology modeling and docking studies of Comamonas testosteroni B-356 biphenyl-2,3-dioxygenase involved in degradation of polychlorinated biphenylsInt J Biol Macromol201046475319879892
- CespedesMVEspinaCGarcia-CabezasMAOrthotopic microinjection of human colon cancer cells in nude mice induces tumor foci in all clinically relevant metastatic sitesAm J Pathol20071701077108517322390
- AmaraAGallSLSchwartzOHIV coreceptor downregulation as antiviral principle: SDF-1alpha-dependent internalization of the chemokine receptor CXCR4 contributes to inhibition of HIV replicationJ Exp Med19971861391469207008
- ZhouNMLuoZWLuoJSHallJWHuangZWA novel peptide antagonist of CXCR4 derived from the N-terminus of viral chemokine vMIP-IIBiochemistry2000393782378710736178
- FujiiNNakashimaHTamamuraHThe therapeutic potential of CXCR4 antagonists in the treatment of HIVExpert Opin Investig Drugs200312185195
- Ferrer-MirallesNCorcheroJLKumarPBiological activities of histidine-rich peptides; merging biotechnology and nanomedicineMicrob Cell Fact20111010122136342
- KuciaMJankowskiKRecaRCXCR4-SDF-1 signalling, locomotion, chemotaxis and adhesionJ Mol Histol20043523324515339043
- Toledo-RubioVVazquezEPlatasGProtein aggregation and soluble aggregate formation screened by a fast microdialysis assayJ Biomol Screen20101545345720233904
- Domingo-EspinJVazquezEGanzJThe nanoparticulate architecture of protein-based artificial viruses is supported by protein- DNA interactionsNanomedicine (Lond)201161047106121651444
- VazquezECorcheroJLVillaverdeAPost-production protein stability: trouble beyond the cell factoryMicrob Cell Fact2011106021806813
- Martinez-AlonsoMGonzalez-MontalbanNGarcia-FruitosEVillaverdeAThe functional quality of soluble recombinant polypeptides produced in Escherichia coli is defined by a wide conformational spectrumAppl Environ Microbiol200810113531358
- RiehemannKSchneiderSWLugerTAGodinBFerrariMFuchsHNanomedicine – challenge and perspectivesAngew Chem Int Ed Engl20094887289719142939
- DietzGPBahrMDelivery of bioactive molecules into the cell: the Trojan horse approachMol Cell Neurosci2004278513115485768
- DuncanRGasparRNanomedicine(s) under the microscopeMol Pharm201182101214121974749
- ThurberGMSchmidtMMWittrupKDFactors determining antibody distribution in tumorsTrends Pharmacol Sci200829576118179828
- EllisLMHicklinDJResistance to targeted therapies: refining anticancer therapy in the era of molecular oncologyClin Cancer Res2009157471747820008847
- JainMVenkatramanGBatraSKOptimization of radioimmunotherapy of solid tumors: biological impediments and their modulationClin Cancer Res2007131374138217309914
- LaakkonenPVuorinenKHoming peptides as targeted delivery vehiclesIntegr Biol (Camb)2010232633720657951
- EnbackJLaakkonenPTumour-homing peptides: tools for targeting, imaging and destructionBiochem Soc Trans20073578078317635147
- MocellinSLiseMNittiDTargeted therapy for colorectal cancer: mapping the wayTrends Mol Med20051132733515950539
- RusconiSScozzafavaAMastrolorenzoASupuranCTAn update in the development of HIV entry inhibitorsCurr Top Med Chem200771273128917627557
- SegalNHSaltzLBEvolving treatment of advanced colon cancerAnnu Rev Med20096020721919630571
- EgorovaAKiselevAHakliMRuponenMBaranovVUrttiAChemokine-derived peptides as carriers for gene delivery to CXCR4 expressing cellsJ Gene Med20091177278119562713
- SleemanJSteegPSCancer metastasis as a therapeutic targetEur J Cancer2010461177118020307970
- SkipperHESchabelFMJrMellettLBImplications of biochemical, cytokinetic, pharmacologic, and toxicologic relationships in the design of optimal therapeutic schedulesCancer Chemother Rep1970544314505527023
- VillaverdeANanotechnology, bionanotechnology and microbial cell factoriesMicrob Cell Fact201095320602780
- VazquezEVillaverdeAEngineering building blocks for self- assembling protein nanoparticlesMicrob Cell Fact2010910121192790
- SadatmousaviPSoltaniMNazarianRJafariMChenPSelf-assembling peptides: potential role in tumor targetingCurr Pharm Biotechnol2011121089110021470142
- ZhaoYTanakaMKinoshitaTHiguchiMTanTSelf-assembling peptide nanofiber scaffolds for controlled release governed by gelator design and guest sizeJ Control Release201014739239920709121
- KyleSAggeliAInghamEMcPhersonMJRecombinant self- assembling peptides as biomaterials for tissue engineeringBiomaterials2010319395940520932572
- HuangHSunXSRational design of responsive self-assembling peptides from native protein sequences (dagger)Biomacromolecules2010113390339421080625
- WuWXingLZhouBLinZActive protein aggregates induced by terminally attached self-assembling peptide ELK16 in Escherichia coliMicrob Cell Fact201110921320350